Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 2 of 144 pages < 1 2 3 4 > Last ›
HSL16858
Former Johnson & Johnson exec charged in Britain
Business Week 2009 Dec 1
http://www.businessweek.com/ap/financialnews/D9CAI8VG0.htm
HSL16871
Goldstein J
How a Decades-Old Drug Is Still a Patented Blockbuster
The Wall Street Journal Blog 2009 Dec 1
http://blogs.wsj.com/health/2009/12/01/how-a-decades-old-drug-is-still-a-patented-blockbuster/
HSL16932
Hall DV, Jones SC, Iverson DC
Content analysis of disease awareness advertisements in popular Australian women's magazines
Med J Aust 2009 Dec 1; 191:(11/12):625-629
http://www.mja.com.au/public/issues/191_11_071209/hal10631_fm.html
HSL17198
López Hidalgo MJ, Aguado Gómez A, Sánchez Ruiz M, García-Moreno Rodríguez G, Alejandre Lázaro G.
[How are the websites of pharmaceutical companies directed at users?]
Aten Primaria 2009 Dec 1;
http://www.ncbi.nlm.nih.gov/pubmed/19959257
HSL17199
Price DW, Raebel MA, Conner DA, Wright LA, Carroll NM.
Pharmaceuticals from development to practice: learnings from an online curriculum.
Am J Manag Care 2009 Dec 1; 15:(12):e109-14
http://www.ncbi.nlm.nih.gov/pubmed/19954269
HSL17200
Vitry AI.
Does direct-to-consumer prescription drug advertising do more harm than good?
Ann Intern Med 2009 Dec 1; 151:(11):823-4
http://www.annals.org/content/151/11/823.4.long
HSL17484
Renckens CNM
In the Interest of All Who Value Their Purse and Their Health
Dutch Society Against Quackery 2009 Dec 1; 32:(4):343-348
http://ehp.sagepub.com/cgi/content/abstract/32/4/343
HSL16820
The Differing Views Of Using Social Media In Pharma
Life Science Leader Magazine 2009 Dec
http://www.lifescienceleader.com/index.php?option=com_jambozine&layout=article&view=page&aid=3922
HSL16921
Atkinson JDM, Jones R
Intellectual property and its role in the pharmaceutical industry
Future Medicinal Chemistry 2009 Dec; 1:(9):1547-1550
www.future-science.com/doi/full/10.4155/fmc.09.138
HSL16922
Mintzes B, Mangin D
Opinion: Direct-to-consumer advertising of prescription medicines: a counter argument
Future Medicinal Chemistry 2009 Dec; 1:(9):1555-1560
www.future-science.com/doi/full/10.4155/fmc.09.136
HSL16960
Kennedy MS.
If it's too good to be true, it probably is.
Am J Nurs 2009 Dec; 109:(12):7
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=LQGJ0vvkQvM2lp0DDMkV0kPBmTmKpRfm4wJGhnQJ4KMqVNFGtHvG!797288596!181195629!8091!-1?issn=0002-936X&volume=109&issue=12&spage=7
HSL17134
Abraham J.
Partial progress: governing the pharmaceutical industry and the NHS, 1948-2008.
J Health Polit Policy Law 2009 Dec; 34:(6):931-77
http://jhppl.dukejournals.org/cgi/reprint/34/6/931?view=long&pmid=20018987
HSL17160
Lupton JR.
Scientific substantiation of claims in the USA: focus on functional foods.
Eur J Nutr 2009 Dec; 48:
http://www.springerlink.com/content/b4h17702u832284u/
HSL18282
Muller N.
The age of social media and marketing--for sale: incontinence drugs and devices.
Ostomy Wound Manage 2009 Dec; 55:(12):23
http://www.ncbi.nlm.nih.gov/pubmed/20560226
HSL16819
Consumers Pay Little or No Attention to Drug Company's Advertised Risk Disclosures, Latest Under the Skin Study from ORC Guideline Finds
Pharma Live 2009 Nov 30
http://pharmalive.com/news/index.cfm?articleID=669780
HSL16857
Heisel W
The Mittleman Files, Part 2: Just another day on the ghostwriting assembly line
Reporting on Health: Antidote: New Ways to Investigate Untold Health Stories 2009 Nov 30
http://www.reportingonhealth.org/blogs/mittleman-files-part-2-just-another-day-ghostwriting-assembly-line
HSL16870
Consumers Pay Little or No Attention to Drug Company’s Advertised Risk Disclosures, Latest Under the Skin Study from ORC Guideline Finds
Opinion Research Corporation 2009 Nov 30
http://www.opinionresearch.com/fileSave/Under_the_Skin_11_30FINAL.pdf
HSL16874
Mundy A
How Industry Spends $1 Billion a Year on Continuing Medical Ed.
The Wall Street Journal Blog 2009 Nov 30
http://blogs.wsj.com/health/2009/11/13/how-industry-spends-1-billion-a-year-on-continuing-medical-ed/
HSL16886
Poses RM
How Industry Views the Research It Sponsors
Health Care Renewal Blog 2009 Nov 30
http://hcrenewal.blogspot.com/2009/11/how-industry-views-research-it-sponsors.html
HSL16817
Lawton V
Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No
BMJ 2009 Nov 29; 339:
http://www.bmj.com/cgi/content/full/339/nov27_1/b4953
HSL16818
Goldacre B
Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes
BMJ 2009 Nov 29; 339:
http://www.bmj.com/cgi/content/full/339/nov27_1/b4949
HSL16821
Jack A
The fall of the world’s best-selling drug
The Finanical Times 2009 Nov 28
http://www.ft.com/cms/s/2/d0f7af5c-d7e6-11de-b578-00144feabdc0.html
HSL16816
Davidson R
Are Big Pharma and the PDUFA to Blame for Healthcare Mess?
OpEdNews 2009 Nov 27
http://www.opednews.com/articles/Are-Big-Pharma-and-the-PDU-by-Robert-Davidson-091126-534.html
HSL16888
Poses RM
More Evidence for Suppression of Research: the Case of Lamictal for Depression
Health Care Renewal Blog 2009 Nov 27
http://hcrenewal.blogspot.com/2009/11/more-evidence-for-suppression-of.html
HSL16890
Brody H
Another Example of Spin in Published Results of Industry-Sponsored Clinical Trials
Hooked: Ethics, Medicine and Pharma 2009 Nov 27
http://brodyhooked.blogspot.com/2009/11/another-example-of-spin-in-published.html
HSL16804
Ecuador overrides 2,000 pharma patents
PM Live 2009 Nov 26
http://www.pmlive.com/find_an_article/allarticles/categories/General/2009/october/news/ecuador_overrides_2,000_pharma_patents
HSL16815
Song F, Parekh-Bhurke S, Hooper L, Loke YK, Ryder JJ, Sutton AJ, Hing CB, Harvey I
Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies
BMC Medical Research Methodology 2009 Nov 26; 9:(79):
http://www.biomedcentral.com/1471-2288/9/79/abstract
HSL16861
Leach B
Boots: 'we sell homeopathic remedies because they sell, not because they work'
The Daily Telegraph 2009 Nov 26
http://www.telegraph.co.uk/finance/newsbysector/retailandconsumer/6658864/Boots-we-sell-homeopathic-remedies-because-they-sell-not-because-they-work.html
HSL16832
Silverman E
A Petition To Keep Pfizer Exec Off Canadian Board
Pharmalot 2009 Nov 25
http://www.pharmalot.com/2009/11/a-petition-to-keep-pfizer-exec-off-canadian-board/
HSL16883
Berkovic N
ADHD panel's drugs links being properly `managed'
The Australian 2009 Nov 25
http://www.theaustralian.com.au/news/adhd-panels-drugs-links-being-properly-managed/story-e6frg6n6-1225803464651
HSL16913
Iskowitz M
Health ed. firms benefit from pharma's compliance woes
Medical Marketing & Media 2009 Nov 25
http://www.mmm-online.com/health-ed-firms-benefit-from-pharmas-compliance-woes/article/158532/
HSL17264
Blum JA, Freeman K, Dart RC, Cooper RJ
Requirements and Definitions in Conflict of Interest Policies of Medical Journals
JAMA 2009 Nov 25; 302:(20):2230-2234.
http://jama.ama-assn.org/cgi/content/abstract/302/20/2230?etoc
HSL16812
Antidepressants: benefit of reboxetine not proven
Institute for Quality and Efficiency in Health Care 2009 Nov 24
http://www.iqwig.de/index.981.en.html?random=27d016
HSL16894
Edwards J
Study Showing Drug Ads Are Linked to Higher Prices Has Flaws
BNet 2009 Nov 24
http://industry.bnet.com/pharma/10005489/study-showing-drug-ads-are-linked-to-higher-prices-has-flaws/
HSL16808
Law MR, Soumerai SB, Adams AS, Majumdar SR
Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid
Arch Intern Med 2009 Nov 23; 169:(21):1969-1974.
http://archinte.ama-assn.org/cgi/content/abstract/169/21/1969?etoc
HSL16822
Drug Ads Ineffective for Boosting Sales, Could Cost Taxpayers: UBC-Harvard Study
PharmaLive 2009 Nov 23
http://pharmalive.com/news/index.cfm?articleID=669141
HSL16823
Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM
Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data
Arch Intern Med 2009 Nov 23; 169:(21):1976-1985.
http://archinte.ama-assn.org/cgi/content/abstract/169/21/1976
HSL16824
Woloshin S, Schwartz LM
Bringing the FDA's Information to Market
Arch Intern Med 2009 Nov 23; 169:(21):1985-1987
http://archinte.ama-assn.org/cgi/content/extract/169/21/1985
HSL16825
Direct-to-Consumer Offers for Free and Discounted Medications on the Internet: A Content Analysis of 'e-Samples'
Arch Intern Med 2009 Nov 23; 169:(21):2024-2030.
http://archinte.ama-assn.org/cgi/content/extract/169/21/2024
HSL16862
Taylor L
US drugmakers' fury over price probe demands
Pharma Times 2009 Nov 23
http://www.pharmatimes.com/WorldNews/article.aspx?id=16948
HSL16864
Sikora K
ADHD guidelines pulled after payment scandal
The Daily Telegraph 2009 Nov 23
http://www.news.com.au/national/adhd-guidelines-pulled-after-payment-scandal/story-e6frfkvr-1225801902002
HSL16807
Hamza W
Pharma cos pressurise govt to legalise DTCAs
The Nation 2009 Nov 22
http://www.nation.com.pk/pakistan-news-newspaper-daily-english-online/Business/22-Nov-2009/Pharma-cos-pressurise-govt-to-legalise-DTCAs
HSL16901
Pharma, Evidence, and Trust
Evidence in Medicine 2009 Nov 21
http://www.evidenceinmedicine.org/2009/11/pharma-evidence-and-trust.html
HSL16814
Damman OC, Hendriks M, Rademakers J, Delnoij DMJ, Groenewegen PP
How do healthcare consumers process and evaluate comparative healthcare information? A qualitative study using cognitive interviews
BMC Public Health 2009 Nov 20; 9:(423):
http://www.biomedcentral.com/1471-2458/9/423/abstract
HSL16866
Feeley J, Cronin Fisk M
AstraZeneca Judge to Urge Return of Seroquel Cases to Courts
Bloomberg.com 2009 Nov 19
http://www.bloomberg.com/apps/news?pid=20601103&sid=asXBF7VliqVQ
HSL16873
Goldstein J
In Medical Research, Who Should Define Conflict of Interest?
The Wall Street Journal Blog 2009 Nov 19
http://blogs.wsj.com/health/2009/11/19/in-medical-research-who-should-define-conflict-of-interest/
HSL16833
Harris G
Academic Researchers’ Conflicts of Interest Go Unreported
The New York Times 2009 Nov 18
http://www.nytimes.com/2009/11/19/health/policy/19nih.html
HSL16850
Lazarus D
The danger of marketing prescription drugs online
The LA Times 2009 Nov 18
http://www.latimes.com/business/la-fi-lazarus18-2009nov18,0,4079474,full.column
HSL16895
Edwards J
Bayer Tries New Google Drug Ad Format But Lawyers Spoil the Party
BNet 2009 Nov 18
http://industry.bnet.com/pharma/10005361/bayer-tries-new-google-drug-ad-format-but-lawyers-spoil-the-party/
HSL16906
Wilson D
Rising Prices of Drugs Lead to Call for Inquiry
The New York Times 2009 Nov 18
http://www.nytimes.com/2009/11/19/health/policy/19drugs.html
HSL16919
Selker HP, Wood AJJ
Industry Influence on Comparative-Effectiveness Research Funded through Health Care Reform
NEJM 2009 Nov 18;
http://healthcarereform.nejm.org/?p=2364
HSL18945
Rosenberg M
Pediatric Zyprexa Brochures Embarrass British Health Service
OpEdNews 2009 Nov 18
http://www.opednews.com/articles/Pediatric-Zyprexa-Brochure-by-Martha-Rosenberg-091118-587.html
HSL16802
Future Physicians Develop Conflict Of Interest Curriculum For Nation's Academic Medical Centers
Medical News Today 2009 Nov 17
http://www.medicalnewstoday.com/articles/171126.php
HSL16806
McMahon AD, Conway DI, MacDonald TM, McInnes GT
The Unintended Consequences of Clinical Trials Regulations
PLoS Med 2009 Nov 17;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000131
HSL16834
Wilson D
Medical Schools Quizzed on Ghostwriting
The New York Times 2009 Nov 17
http://www.nytimes.com/2009/11/18/business/18ghost.html
HSL16835
Silverman E
100 Researchers Ask NIH To Fund Ethics Research
Pharmalot 2009 Nov 17
http://www.pharmalot.com/2009/11/100-researchers-ask-nih-to-fund-ethics-research/
HSL16851
O'Brien J
O'Brien: Just say no to online drug ads
Mercury News 2009 Nov 17
http://www.mercurynews.com/business/ci_13809505?nclick_check=1
HSL17004
Basken C
Ethicists Prod NIH to Spend Money Investigating Conflicts of Interest
The Chronicle of Higher Education 2009 Nov 17
http://chronicle.com/article/Ethicists-Prod-NIH-to-Spend/49183/
HSL16867
Study says drug does little, proving need for more testing
The Boston Globe 2009 Nov 16
http://www.boston.com/bostonglobe/editorial_opinion/editorials/articles/2009/11/16/study_says_drug_does_little_proving_need_for_more_testing/
HSL16865
Wilson D
Drug Makers Raise Prices in Face of Health Care Reform
The New York Times 2009 Nov 15
http://www.nytimes.com/2009/11/16/business/16drugprices.html?_r=1
HSL16868
Herper M
Another Vytorin Mess For Merck
Forbes 2009 Nov 15
http://www.forbes.com/2009/11/15/zetia-merck-vytorin-business-health-care-pharmaceuticals.html
HSL16829
Pear R
In House, Many Spoke With One Voice: Lobbyists’
The New York Times 2009 Nov 14
http://www.nytimes.com/2009/11/15/us/politics/15health.html?_r=1&pagewanted=all
HSL16836
Silverman E
House Bill Wants Pharma To Disclose CME Funding
Pharmalot 2009 Nov 13
http://www.pharmalot.com/2009/11/house-bill-wants-pharma-to-disclose-cme-funding/#more-19838
HSL16877
Goldstein J
Google’s Pitch to FDA for Online Drug Ads
The Wall Street Journal Blog 2009 Nov 13
http://blogs.wsj.com/health/2009/11/13/googles-pitch-to-fda-for-online-drug-ads/
HSL16911
Arnold M
Outlook 2010: A New Dawn
Medical Marketing & Media 2009 Nov 13
http://www.mmm-online.com/outlook-2010-a-new-dawn/article/158861/
HSL16790
Johnson LA
Review: Reporting on Pfizer drug studies fudged
The Associated Press 2009 Nov 12
http://www.cnycentral.com/news/story.aspx?id=375781
HSL16791
Vedula SS, Bero L, Scherer RW, Dickersin K
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
NEJM 2009 Nov 12; 361:(20):1963-1971
http://content.nejm.org/cgi/content/short/361/20/1963
HSL16792
Grogan K
Pfizer critical of 'selective outcome reporting' study
Pharma Times 2009 Nov 12
http://www.pharmatimes.com/WorldNews/article.aspx?id=16902
HSL16794
Bowcott O
Chemical restraints killing dementia patients
The Guardian 2009 Nov 12
http://www.guardian.co.uk/society/2009/nov/12/anti-psychotic-drugs-kill-dementia-patients
HSL16795
Steel E
Drug Makers to Press for Guidance on Web Marketing
The Wall Street Journal 2009 Nov 12B4
http://voices.allthingsd.com/20091112/drug-makers-to-press-for-guidance-on-web-marketing/
HSL16801
Seetharaman D
UPDATE 1-U.S. FDA tackles gray area of social media
Reuters 2009 Nov 12
http://www.reuters.com/article/companyNewsAndPR/idUSN1242207720091112
HSL16837
Scarcella M
DOJ Targets Pharmaceutical Industry for FCPA Enforcement
The Legal Times Blog 2009 Nov 12
http://legaltimes.typepad.com/blt/2009/11/doj-targets-pharmaceutical-industry-for-fcpa-enforcement.html
HSL16878
Hensley S
Google Has A Plan For Safer, More Useful Online Drug Ads
npr 2009 Nov 12
http://www.npr.org/blogs/health/2009/11/google_has_a_plan_for_safer_on.html#more
HSL16879
Lewis-Hall FC
Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools
National Transportation Safety Board Conference Center 2009 Nov 12
http://online.wsj.com/public/resources/documents/DrFredaLewis-Hall.pdf
HSL16884
US Department of Health and Human Services FDA
Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing
2009 Nov 12
http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM193462.pdf
HSL16892
Brody H
COI: Define It Narrowly Enough and It Goes Away
Hooked: Ethics, Medicine and Pharma 2009 Nov 12
http://brodyhooked.blogspot.com/2009/11/coi-define-it-narrowly-enough-and-it.html
HSL16920
Thomaselli R
PhRMA Proposes FDA-Approved Logo for Marketing in Social Media Industry, Government Grapple With New Frontier in Day 1 of Hearings
The Advertising Age 2009 Nov 12
http://adage.com/abstract.php?article_id=140513
HSL17358
Phillips D
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNet 2009 Nov 12
http://industry.bnet.com/pharma/10005261/fda-looking-to-regulate-biogens-invisible-salesforce/
HSL16773
O'Hara M
Dangers of giving air time to TV's drug pushers
The Guardian 2009 Nov 11
http://www.guardian.co.uk/society/2009/nov/11/mental-health-health
HSL16811
Irwin T
FDA Ponders Rules For Online Pharma Ads
MarketingDaily 2009 Nov 11
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=117266
HSL16838
Silverman E
What Changes? Pfizer Fudged Neurontin Studies
Pharmalot 2009 Nov 11
http://www.pharmalot.com/2009/11/what-changes-pfizer-fudged-neurontin-trial-results/
HSL16772
Grant B
The blogopharmasphere?
The Scientist 2009 Nov 10
http://www.the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/56142&id=56142
HSL16774
Iskowitz M
Bid to restrict industry-backed CME rebuffed, again
Medical Marketing & Media 2009 Nov 10
http://www.mmm-online.com/Bid-to-restrict-industry-backed-CME-rebuffed-again/article/157524/?DCMP=EMC-MMM_Newsbrief
HSL16779
Gérvas J, Wright J
Please may we have an RCT now?
BMJ 2009 Nov 10; 339:
http://www.bmj.com/cgi/content/extract/339/nov10_1/b4651?papetoc
HSL16780
Silverman E
So Maybe DTC Ads Aren’t Worth It, After All
Pharmalot 2009 Nov 10
http://www.pharmalot.com/2009/11/so-maybe-dtc-ads-arent-worth-it-after-all/
HSL16908
Staton T
Justice eyes marketing at J&J, Forest
Fierce Pharma 2009 Nov 10
http://www.fiercepharma.com/story/justice-eyes-marketing-j-j-forest/2009-11-10
HSL16775
Seetharaman D
US drugmakers urge FDA safety logo for Internet
Reuters 2009 Nov 9
http://www.reuters.com/article/rbssHealthcareNews/idUSN0927327020091109
HSL16777
Evans D
Pfizer Broke the Law by Promoting Drugs for Unapproved Uses
Bloomberg.com 2009 Nov 9
http://www.bloomberg.com/apps/news?pid=20601109&sid=a4yV1nYxCGoA&pos=10
HSL16778
Silverman E
Forest Labs In Tentative Deal Over Marketing Probe
Pharmalot 2009 Nov 9
http://www.pharmalot.com/2009/11/forest-labs-in-tentative-deal-over-marketing-probe/
HSL16793
Jewett C, Roe S,
Doctor-drugmaker ties: Psychiatrist Dr. Michael Reinstein received nearly $500,000 from antipsychotic drug's manufacturer
The Chicago Tribune 2009 Nov 9
http://www.chicagotribune.com/health/chi-drugs-seroquel-reinsteinnov11,0,172967,full.story
HSL16839
Verilogue Study: Does Higher DTC Spending Result in Positive Patient-Physician Conversations?
Verilogue 2009 11 09
http://www.verilogue.com/press_8.php
HSL16907
Loftus P
Forest Labs In Tentative Pact To Settle US Civil Probe >FRX
The Wall Street Journal 2009 Nov 9
http://english.capital.gr/dj/news.asp?details=849549
HSL16938
Shrader-Frechette K.
Climate Change, Nuclear Economics, and Conflicts of Interest.
Sci Eng Ethics 2009 Nov 8;
http://www.springerlink.com/content/k246p062836210m0/
HSL16781
Silverman E
Abbott Labs Probed Over Depakote Marketing
Pharmalot 2009 Nov 6
http://www.pharmalot.com/2009/11/abbott-labs-probed-over-depakote-marketing/
HSL16782
Silverman E
Marketing Nexium As Superior To Prilosec Was OK
Pharmalot 2009 Nov 6
http://www.pharmalot.com/2009/11/marketing-nexium-as-superior-to-prilosec-was-ok/
HSL16896
Edwards J
AstraZeneca's New Blog Is Slammed by Critics
BNet 2009 Nov 6
http://industry.bnet.com/pharma/10005180/astrazenecas-new-blog-is-slammed-by-critics/
HSL16768
Dorschner J
Controversial psychiatrist to head UM medical school department
The Miami Herald 2009 Nov 5
http://www.cchrint.org/2009/11/05/nemeroff-lands-psych-chairmanship/
HSL16776
Arnold M
CEOs trump movie stars among celeb endorsers, says survey
Medical Marketing & Media 2009 Nov 4
http://www.mmm-online.com/CEOs-trump-movie-stars-among-celeb-endorsers-says-survey/article/157067/
HSL16880
Goldstein J
Antipsychotic Drugs, Elderly Patients and Omnicare’s Settlement
The Wall Street Journal Blog 2009 Nov 4
http://blogs.wsj.com/health/2009/11/04/antipsychotic-drugs-elderly-patients-and-the-omnicare-settlement/
HSL16897
Weintraub A
Ask Your Doctor If This Ad Is Right for You
Business Week 2009 Nov 4
http://www.businessweek.com/magazine/content/09_46/b4155078964719.htm
Page 2 of 144 pages < 1 2 3 4 > Last ›
